We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
-2.39%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$2.27M
Cap. Flow
+$10.4M
Cap. Flow %
6.01%
Top 10 Hldgs %
63.46%
Holding
237
New
6
Increased
44
Reduced
166
Closed
21

Top Buys

Rank Stock Value
1
CBUS icon
Cibus
CBUS
+$22.7M
2
BW icon
Babcock & Wilcox
BW
+$14.2M
3
CMA
Comerica
CMA
+$237K
4
PANW icon
Palo Alto Networks
PANW
+$207K
5
ZION icon
Zions Bancorporation
ZION
+$206K

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$12.6M
2
SSPY icon
Syntax Stratified LargeCap ETF
SSPY
+$2.72M
3
KYNB
Kyntra Bio
KYNB
+$1.59M
4
ADCT icon
ADC Therapeutics
ADCT
+$676K
5
SMDY
Syntax Stratified MidCap ETF
SMDY
+$341K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Industrials 9.63%
3 Technology 6.93%
4 Consumer Staples 6.52%
5 Consumer Discretionary 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSPY icon
1
Syntax Stratified LargeCap ETF
SSPY
$129M
$49.8M 28.65%
730,293
-41,541
-5% -$2.72M
RPRX icon
2
Royalty Pharma
RPRX
$25.9B
$20M 11.51%
650,690
-371,504
-36% -$12.6M
BW icon
3
Babcock & Wilcox
BW
$1.39B
$14.3M 8.2%
+2,416,200
New +$14.2M
CBUS icon
4
Cibus
CBUS
$147M
$13.3M 7.63%
+1,262,842
New +$22.7M
SMDY
5
DELISTED
Syntax Stratified MidCap ETF
SMDY
$5.9M 3.4%
152,389
-9,283
-6% -$341K
SSLY
6
DELISTED
Syntax Stratified SmallCap ETF
SSLY
$2.93M 1.68%
67,763
-1,837
-3% -$76.2K
ADCT icon
7
ADC Therapeutics
ADCT
$134M
$1.9M 1.1%
885,520
-300,695
-25% -$676K
COST icon
8
Costco
COST
$422B
$765K 0.44%
1,420
-201
-12% -$102K
WMT icon
9
Walmart Inc
WMT
$885B
$753K 0.43%
14,364
-2,364
-14% -$119K
SYY icon
10
Sysco
SYY
$40.8B
$750K 0.43%
10,111
-325
-3% -$24K
KR icon
11
Kroger
KR
$35.4B
$746K 0.43%
15,878
-337
-2% -$16.1K
XOM icon
12
ExxonMobil
XOM
$644B
$734K 0.42%
6,843
-241
-3% -$26.3K
CVX icon
13
Chevron
CVX
$392B
$728K 0.42%
4,626
-155
-3% -$24.9K
CVS icon
14
CVS Health
CVS
$133B
$628K 0.36%
9,079
+273
+3% +$19.4K
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
$591K 0.34%
20,759
+344
+2% +$11.2K
DPZ icon
16
Domino's
DPZ
$11.5B
$551K 0.32%
1,636
-62
-4% -$19.6K
CHTR icon
17
Charter Communications
CHTR
$17.3B
$546K 0.31%
1,487
-57
-4% -$19.4K
EL icon
18
Estee Lauder
EL
$30.4B
$544K 0.31%
2,768
+615
+29% +$130K
ROST icon
19
Ross Stores
ROST
$80.5B
$532K 0.31%
4,743
-144
-3% -$15.1K
KYNB
20
Kyntra Bio
KYNB
$27.2M
$528K 0.3%
7,828
-3,840
-33% -$1.59M
AAPL icon
21
Apple
AAPL
$4.54T
$525K 0.3%
2,706
-720
-21% -$125K
TJX icon
22
TJX Companies
TJX
$174B
$523K 0.3%
6,166
-686
-10% -$54.1K
CHD icon
23
Church & Dwight Co
CHD
$23.4B
$521K 0.3%
5,195
-873
-14% -$82.2K
MSI icon
24
Motorola Solutions
MSI
$72.3B
$516K 0.3%
1,760
-187
-10% -$53.6K
RL icon
25
Ralph Lauren
RL
$22.6B
$514K 0.3%
4,171
-320
-7% -$36.9K
1
2 3 4 5

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q2 2023 Portfolio in Review

As of Q2 2023, Vantage Consulting Group held 237 positions worth $174M, down 1.3% from $176M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Vantage Consulting Group deployed $10.4M of net new capital in Q2 2023, opening 6 new positions and adding to 44 existing holdings. Its largest new stake was Cibus: 1,262,842 shares worth $13.3M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Royalty Pharma, an estimated $12.6M trimmed.

  • Vantage Consulting Group's largest Q2 2023 buy was Cibus: 1,262,842 shares worth $13.3M.
  • Vantage Consulting Group added most to Comerica in Q2 2023, an estimated $237K increase.
  • Vantage Consulting Group's biggest Q2 2023 reduction was Royalty Pharma, cutting an estimated $12.6M.
  • Vantage Consulting Group fully exited General Mills in Q2 2023, selling an estimated $237K.
  • Vantage Consulting Group's ten largest holdings make up 63% of its $174M portfolio in Q2 2023.
  • Vantage Consulting Group opened 6 new positions and closed 21 in Q2 2023.
  • Vantage Consulting Group's portfolio value fell 1.3% quarter-over-quarter to $174M.

Based on Vantage Consulting Group's 13F filing for Q2 2023, filed 11 Aug 2023.